CCN2 and pulmonary fibrosis: Research has indicated that COVID‐19 exacerbates fibrosis in individuals with pulmonary fibrosis,95 and elevated levels of CTGF and TGF‐β have been observed in AECs infected with SARS‐CoV‐2.96